Eskayef (Now Known ASmithkline Beecham Pharmaceutical(India) Ltd. Etc. vs Commissioner Of Income Tax
In this landmark Supreme Court judgment, the Revenue prevailed on both contested issues. First, following precedent, surtax liability was held non-deductible. Second, and more significantly, the Court established that pharmaceutical companies’ expenditure on distributing physician’s samples of prescription drugs qualifies as ‘publicity and sales promotion’ under section 37(3A) of the Income Tax Act, 1961. This subjects such expenditure to statutory restrictions on deductibility, rejecting arguments that it was for feedback or constituted ‘bare minimum’ business expenditure. The decision clarifies the broad interpretation of promotional activities under tax law, particularly for regulated industries like pharmaceuticals.
